DECISION-CTO: a "negative" clinical trial? Really? En savoir plus sur DECISION-CTO: a "negative" clinical trial? Really?
Heterozygous PDGFRB Mutation in a Three-generation Family with Autosomal Dominant Infantile Myofibromatosis. En savoir plus sur Heterozygous PDGFRB Mutation in a Three-generation Family with Autosomal Dominant Infantile Myofibromatosis.
Paraganglioma of the bladder in a kidney transplant recipient: A case report. En savoir plus sur Paraganglioma of the bladder in a kidney transplant recipient: A case report.
The expansion of endoscopic submucosal dissection in France: A prospective nationwide survey. En savoir plus sur The expansion of endoscopic submucosal dissection in France: A prospective nationwide survey.
Circulating Klotho associates with cardiovascular morbidity and mortality during hemodialysis. En savoir plus sur Circulating Klotho associates with cardiovascular morbidity and mortality during hemodialysis.
Inappropriate implantable cardioverter-defibrillator shocks in Brugada syndrome: Pattern in primary and secondary prevention. En savoir plus sur Inappropriate implantable cardioverter-defibrillator shocks in Brugada syndrome: Pattern in primary and secondary prevention.
Dynamic contrast-enhanced MR imaging in osteoid osteoma: relationships with clinical and CT characteristics. En savoir plus sur Dynamic contrast-enhanced MR imaging in osteoid osteoma: relationships with clinical and CT characteristics.
Prognosis of Isolated First-Trimester Fetal Megacystis with Spontaneous Resolution. En savoir plus sur Prognosis of Isolated First-Trimester Fetal Megacystis with Spontaneous Resolution.
Nab-paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil as first-line therapy for metastatic pancreatic adenocarcinoma (AFUGEM GERCOR): a non-comparative, multicentre, open-label, randomised phase 2 trial. En savoir plus sur Nab-paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil as first-line therapy for metastatic pancreatic adenocarcinoma (AFUGEM GERCOR): a non-comparative, multicentre, open-label, randomised phase 2 trial.
The burden and epidemiology of community-acquired central nervous system infections: a multinational study. En savoir plus sur The burden and epidemiology of community-acquired central nervous system infections: a multinational study.